PERSPECTA

News from every angle

← Back to headlines

Sanofi's MenQuadfi Approved in EU for Infant Meningococcal Disease

Sanofi's MenQuadfi vaccine has received approval in the European Union for use in infants to protect against meningococcal disease.

4 Aug, 09:12 — 4 Aug, 09:12
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed23d ago

Sanofi’s MenQuadfi approved in EU for infants against meningococcal disease

Read full article →

Related Stories

TotalEnergies Completes Exit From Russia’s Arctic LNG 2 Project

33m ago

US FTC Launches Probe Into YouTube’s Social Media Policies

46m ago

Golf Channel Cancels Show and Callaway Ends Partnership Following Good Good Backlash

52m ago

United States Negotiates Major Stake in Venezuelan Oil Fields

59m ago